Allylescaline

The onset is characteristically slow, unfolding over sixty to ninety minutes with a gradually building warmth that begins in the stomach and radiates outward through the body. There is a groundedness to the come-up that immediately distinguishes allylescaline from the sharper, more synthetic-feeling phenethylamines. The energy is earthy and organic, settling into the body like sunlight warming stone. Mild gastrointestinal awareness may be present but rarely develops into troublesome nausea. Colors begin to shift almost imperceptibly, acquiring a golden, sunlit quality that makes the ordinary world look as though it has been photographed during the last hour before sunset.

By the two-hour mark, the visual effects have established themselves as a gentle but unmistakable psychedelic enhancement. Colors are deeply saturated in warm, natural tones -- ochres, sage greens, terracottas, and the rich amber of late-afternoon light. Surfaces breathe slowly and rhythmically, as though the world is gently respiring. Textures reveal extraordinary detail: the grain of wood becomes a landscape, the surface of a leaf unfolds into fractal complexity, and natural forms seem to express a mathematical beauty that is normally hidden beneath the brain's filters of familiarity. The visual geometry is soft, organic, and flowing -- spirals, waves, and rounded forms that feel distinctly mescaline-adjacent, echoing the aesthetics of the parent compound without quite reaching its depth.

The headspace is calm, clear, and gently expansive. There is a philosophical quality to the thoughts that arise -- a tendency toward quiet contemplation of nature, beauty, and connectedness. The mind feels unhurried and spacious, with none of the frantic branching or analytical intensity of substances like 2C-E. Emotional warmth is present but gentle, manifesting as a quiet gratitude and a softened appreciation for the present moment. Music is beautifully enhanced, acquiring a depth and resonance that rewards careful listening. The body feels comfortable, warm, and grounded -- there is a sense of being held by the earth, of belonging to the physical world in a way that is simultaneously ordinary and profound.

The duration is long, spanning eight to twelve hours with a slow, gradual arc that never spikes into overwhelming intensity. The descent is smooth and leisurely, with effects fading gently over the final hours. The aftermath is clean and often includes a lingering afterglow of visual sensitivity and emotional openness. Allylescaline offers a mescaline-like experience with reduced intensity and fewer demands -- a long, gentle walk through a psychedelic landscape that never requires running.

Mechanism of Action

Allylescaline acts as a partial agonist at serotonin 5-HT2A receptors, consistent with all classical phenethylamine psychedelics. The substitution of the 4-methoxy group with a 4-allyloxy group appears to maintain or enhance 5-HT2A affinity relative to mescaline, consistent with the greater potency by weight.

Comparison to Mescaline

The key pharmacological difference between allylescaline and mescaline is the replacement of the 4-methoxy oxygen-methyl linkage with an oxygen-allyl linkage. This modification:

• Increases lipophilicity, likely enhancing CNS penetration
• Reduces the accessibility of the 4-oxygen to metabolic O-demethylation, potentially extending duration
• May alter the geometry of receptor engagement in ways that explain the qualitative character differences users report

The 5–8 fold greater potency of allylescaline relative to mescaline by weight is consistent with the enhanced lipophilicity and metabolic stability hypothesis.

Additional Receptor Activity

Like mescaline analogs broadly, allylescaline likely has some affinity for 5-HT2B and 5-HT2C receptors in addition to 5-HT2A. The degree of monoamine transporter activity is low compared to amphetamine-class compounds, consistent with the predominantly psychedelic rather than stimulant character.

Duration

The 8–12 hour duration of allylescaline is comparable to mescaline itself, which is among the longest-duration classical psychedelics. This extended duration relates to metabolic stability and receptor binding kinetics.

Development and PiHKAL

Allylescaline was synthesized by Alexander Shulgin as part of his extended program of mescaline analog exploration. The systematic replacement of mescaline's 4-methoxy group with a variety of alkoxy and other substituents generated a family of compounds including escaline (4-ethoxy), IRIS (4-isopropoxy), proscaline (4-propoxy), and allylescaline (4-allyloxy). These are documented in PiHKAL with synthesis procedures and bioassay notes.

Shulgin's documentation of allylescaline noted its potency and the warmth of its character — qualities that have made it a point of interest for the subset of the psychedelic community specifically interested in mescaline-analog phenomenology.

Legal Status

Allylescaline is not explicitly scheduled in all jurisdictions but is subject to phenethylamine analogue laws in many countries. In the United States, the Federal Analogue Act may apply; in the United Kingdom, it falls under the Psychoactive Substances Act.